EU Fast Track Review Sought For Avacincaptad Pegol, mRNA-1345 & Troriluzole
Executive Summary
The European Medicines Agency is this week expected to consider whether the planned marketing applications for investigational products from Iveric Bio, Moderna and Biohaven merit an accelerated assessment.